Published in Pharmacol Ther on July 17, 2012
Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab (2013) 1.45
Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc (2014) 0.99
Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease. Front Endocrinol (Lausanne) (2014) 0.98
Hippocampal insulin resistance and cognitive dysfunction. Nat Rev Neurosci (2015) 0.97
Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview. J Pharmacovigil (2014) 0.97
Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke. Transl Stroke Res (2015) 0.96
Aberrant insulin signaling in Alzheimer's disease: current knowledge. Front Neurosci (2015) 0.92
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease. Alzheimers Dement (2014) 0.88
Pharmacologic manipulation of lysosomal enzyme transport across the blood-brain barrier. J Cereb Blood Flow Metab (2015) 0.88
Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis. Nat Commun (2016) 0.86
Metabolic syndrome and the immunological affair with the blood-brain barrier. Front Immunol (2015) 0.85
PTP1B inhibition suggests a therapeutic strategy for Rett syndrome. J Clin Invest (2015) 0.84
Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies. Endocrinol Metab Clin North Am (2013) 0.82
Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism. Mol Neurobiol (2015) 0.81
Postsynaptic distribution of IRSp53 in spiny excitatory and inhibitory neurons. J Comp Neurol (2014) 0.80
Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs. Neurodegener Dis Manag (2014) 0.80
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease. Front Aging Neurosci (2016) 0.79
Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hormones of energy balance in a TCDD-sensitive and a TCDD-resistant rat strain. Int J Mol Sci (2014) 0.79
Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases. AAPS J (2015) 0.79
Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines. Nanomedicine (2015) 0.78
MeCP2 co-ordinates liver lipid metabolism with the NCoR1/HDAC3 corepressor complex. Hum Mol Genet (2016) 0.78
The activation of the Akt/PKB signalling pathway in the brains of clozapine-exposed rats is linked to hyperinsulinemia and not a direct drug effect. Psychopharmacology (Berl) (2014) 0.77
Hypothalamic differences in expression of genes involved in monoamine synthesis and signaling pathways after insulin injection in chickens from lines selected for high and low body weight. Neurogenetics (2015) 0.77
Dicholine succinate, the neuronal insulin sensitizer, normalizes behavior, REM sleep, hippocampal pGSK3 beta and mRNAs of NMDA receptor subunits in mouse models of depression. Front Behav Neurosci (2015) 0.77
Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood. Mol Metab (2016) 0.77
Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions. J Alzheimers Dis (2015) 0.77
Awake, long-term intranasal insulin treatment does not affect object memory, odor discrimination, or reversal learning in mice. Physiol Behav (2017) 0.76
Insulin receptor activation in the nucleus accumbens reflects nutritive value of a recently ingested meal. Physiol Behav (2016) 0.76
Long-term high-fat diet induces hippocampal microvascular insulin resistance and cognitive dysfunction. Am J Physiol Endocrinol Metab (2016) 0.76
Relationship between Insulin-Resistance Processing Speed and Specific Executive Function Profiles in Neurologically Intact Older Adults. J Int Neuropsychol Soc (2015) 0.76
Apolipoprotein E Genotype and Sex Influence Glucose Tolerance in Older Adults: A Cross-Sectional Study. Dement Geriatr Cogn Dis Extra (2016) 0.76
Can insulin signaling pathways be targeted to transport Aβ out of the brain? Front Aging Neurosci (2015) 0.76
Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease. Exp Biol Med (Maywood) (2016) 0.76
Nano-enabled delivery of diverse payloads across complex biological barriers. J Control Release (2015) 0.76
The influence of glycemic index on cognitive functioning: a systematic review of the evidence. Adv Nutr (2014) 0.76
The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study. Biomed Res Int (2016) 0.75
Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue. Sci Rep (2015) 0.75
NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface. Fluids Barriers CNS (2017) 0.75
The Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients. Front Psychiatry (2017) 0.75
Dopamine Adaptations as a Common Pathway for Neurocognitive Impairment in Diabetes and Obesity: A Neuropsychological Perspective. Front Neurosci (2017) 0.75
Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits. Curr Opin Behav Sci (2015) 0.75
Peptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brain. PLoS One (2014) 0.75
Insulin resistance in Alzheimer's disease. Transl Res (2016) 0.75
The SAMP8 mouse for investigating memory and the role of insulin in the brain. Exp Gerontol (2016) 0.75
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Dietary Reversal Ameliorates Short- and Long-Term Memory Deficits Induced by High-fat Diet Early in Life. PLoS One (2016) 0.75
Therapeutic effect of vagus nerve stimulation on depressive-like behavior, hyperglycemia and insulin receptor expression in Zucker fatty rats. PLoS One (2014) 0.75
Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model. Sci Rep (2017) 0.75
Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats. Neuroscience (2016) 0.75
Altered Brain Response to Drinking Glucose and Fructose in Obese Adolescents. Diabetes (2016) 0.75
Cerebral insulin, insulin signaling pathway, and brain angiogenesis. Neurol Sci (2015) 0.75
Integrating insulin-like growth factor 1 and sex hormones into neuroprotection: Implications for diabetes. World J Diabetes (2017) 0.75
Evaluating Crossbred Red Rice Variants for Postprandial Glucometabolic Responses: A Comparison with Commercial Varieties. Nutrients (2016) 0.75
Endothelial insulin receptors differentially control insulin signaling kinetics in peripheral tissues and brain of mice. Proc Natl Acad Sci U S A (2017) 0.75
The diabetic brain and cognition. J Neural Transm (Vienna) (2017) 0.75
The role of melatonin in the onset and progression of type 3 diabetes. Mol Brain (2017) 0.75
Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone before: ApoE, APP transcription and AD: Hypothesised mechanisms and existing knowledge gaps. Bioessays (2017) 0.75
The effect of intra-cerebroventricular injection of insulin on nociception of formalin test in non-diabetic and short-term diabetic rat models. Iran J Vet Res (2017) 0.75
Insulin signalling and the regulation of glucose and lipid metabolism. Nature (2001) 16.41
Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 8.14
LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron (2004) 4.29
The influence of the vagus on the islets of Langerhans: Part I. Vagus hypoglycaemia. J Physiol (1925) 4.26
Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat Neurosci (2000) 4.10
Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons. Nat Neurosci (2001) 4.09
Leptin enters the brain by a saturable system independent of insulin. Peptides (1996) 3.97
Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem (1998) 3.77
Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron (2000) 3.73
New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell (2001) 3.52
LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev (2008) 3.46
Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol (1971) 3.26
Insulin receptors are widely distributed in the central nervous system of the rat. Nature (1978) 3.07
Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization. Nat Neurosci (2000) 2.99
Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes (2003) 2.90
Hyperinsulinemia and risk of Alzheimer disease. Neurology (2004) 2.87
Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes (2006) 2.77
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology (1998) 2.61
Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J (2004) 2.56
LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell (1995) 2.37
Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes (2004) 2.33
Insulin increases CSF Abeta42 levels in normal older adults. Neurology (2003) 2.27
Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron (2008) 2.25
Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia (2010) 2.20
Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide. Brain Behav Immun (2005) 2.18
Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature (1997) 2.16
Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest (2000) 2.11
Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis (2008) 2.08
Intranasal insulin improves memory in humans. Psychoneuroendocrinology (2004) 2.03
Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev (1992) 2.03
The role of insulin receptor signaling in the brain. Trends Endocrinol Metab (2005) 2.01
Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am J Physiol Heart Circ Physiol (2006) 1.99
Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett (1994) 1.99
Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier. Proc Natl Acad Sci U S A (2004) 1.97
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol (2006) 1.94
Distribution and degradation studies with insulin I131. J Clin Invest (1954) 1.92
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm (Vienna) (1998) 1.90
Contribution of cytoskeleton to the internalization of AMPA receptors. Proc Natl Acad Sci U S A (2001) 1.83
FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci (2004) 1.79
Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem (1999) 1.77
The source of cerebral insulin. Eur J Pharmacol (2004) 1.73
Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest (1993) 1.67
Regulation of dendritic spine morphogenesis by insulin receptor substrate 53, a downstream effector of Rac1 and Cdc42 small GTPases. J Neurosci (2005) 1.66
Insulin promotes rapid delivery of N-methyl-D- aspartate receptors to the cell surface by exocytosis. Proc Natl Acad Sci U S A (2001) 1.63
Intraventricular insulin and leptin reverse place preference conditioned with high-fat diet in rats. Behav Neurosci (2004) 1.63
Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides (1998) 1.58
Reciprocal interactions of insulin and insulin-like growth factor I in receptor-mediated transport across the blood-brain barrier. Endocrinology (2006) 1.58
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry (1999) 1.57
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol (2004) 1.52
Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc Natl Acad Sci U S A (1994) 1.50
The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J Neurosci (1999) 1.50
Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am J Physiol Regul Integr Comp Physiol (2004) 1.49
Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes (2000) 1.48
Cdc42Hs facilitates cytoskeletal reorganization and neurite outgrowth by localizing the 58-kD insulin receptor substrate to filamentous actin. J Cell Biol (2001) 1.45
Targeting the CNS to treat type 2 diabetes. Nat Rev Drug Discov (2009) 1.45
Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res (1987) 1.42
Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol (2004) 1.42
Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci (2002) 1.36
The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease. Curr Pharm Des (2008) 1.36
Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology (1987) 1.36
Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. J Neurosci (2009) 1.35
Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents. J Clin Invest (1979) 1.34
Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res (2001) 1.34
Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology (1990) 1.32
Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience (1989) 1.30
Insulin receptor signaling in the development of neuronal structure and function. Neural Dev (2010) 1.29
Insulin in the cerebrospinal fluid. Nature (1967) 1.28
Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J Neurosci (2011) 1.28
Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes (1993) 1.28
Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience (1986) 1.25
Energy regulatory signals and food reward. Pharmacol Biochem Behav (2010) 1.25
Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis. J Cell Mol Med (2011) 1.24
TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice. Exp Neurol (2002) 1.24
Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides (1997) 1.22
Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides (1997) 1.20
Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res (2009) 1.20
Origin of insulin receptor-like tyrosine kinases in marine sponges. Biol Bull (1999) 1.18
Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier. Peptides (2008) 1.18
Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur J Pharmacol (2008) 1.18
Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking. PLoS One (2010) 1.17
Low density lipoprotein receptor-related protein 1 promotes anti-apoptotic signaling in neurons by activating Akt survival pathway. J Biol Chem (2009) 1.16
Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial. Diabet Med (2008) 1.13
Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J Clin Invest (1991) 1.12
Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab (2002) 1.12
Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice. Endocrinology (2011) 1.11
Relationship between plasma and cerebrospinal fluid insulin levels of dogs. Am J Physiol (1977) 1.10
Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli. Brain Res (1999) 1.10
Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability. Brain Res Bull (1985) 1.10
Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm (Vienna) (1998) 1.09
Leptin transport across the blood-brain barrier of the Koletsky rat is not mediated by a product of the leptin receptor gene. Brain Res (2002) 1.09
Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin. Peptides (1997) 1.08
Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn Mem (2005) 1.08
Studies of radioactive injected labeled insulin. J Biol Chem (1954) 1.07
Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic. J Neurol (2005) 1.07
Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier. Endocrinology (2008) 1.05
Metabolic syndrome is associated with learning and recall impairment in middle age. Dement Geriatr Cogn Disord (2010) 1.04
Glucose and insulin increase the transport of leptin through the blood-brain barrier in normal mice but not in streptozotocin-diabetic mice. Neuroendocrinology (2001) 1.04
The metabolic syndrome and aging. J Gerontol A Biol Sci Med Sci (2004) 1.04
Increased feeding in response to bilateral injection of insulin antibodies in the VMH. Physiol Behav (1977) 1.04
The blood-brain barrier and immune function and dysfunction. Neurobiol Dis (2009) 2.08
Nitric oxide in cell survival: a janus molecule. Antioxid Redox Signal (2009) 1.37
Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav Immun (2009) 1.32
Measurement of oxidized/reduced glutathione ratio. Methods Mol Biol (2010) 1.20
Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide. J Neuroinflammation (2011) 1.16
Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J Neuroinflammation (2012) 1.09
Nitric oxide isoenzymes regulate lipopolysaccharide-enhanced insulin transport across the blood-brain barrier. Endocrinology (2008) 1.01
Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain. Free Radic Biol Med (2010) 0.95
Nitrative stress in cerebral endothelium is mediated by mGluR5 in hyperhomocysteinemia. J Cereb Blood Flow Metab (2011) 0.93
Proteomics in animal models of Alzheimer's and Parkinson's diseases. Ageing Res Rev (2008) 0.88
Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells. J Pharmacol Exp Ther (2014) 0.87
Lectin-affinity chromatography brain glycoproteomics and Alzheimer disease: insights into protein alterations consistent with the pathology and progression of this dementing disorder. Proteomics Clin Appl (2010) 0.84
The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression. J Neurosci Res (2010) 0.82
Hyperhomocysteinemic mice show cognitive impairment without features of Alzheimer's disease phenotype. J Alzheimers Dis (2013) 0.80
Protective effects of an anti-melanocortin-4 receptor scFv derivative in lipopolysaccharide-induced cachexia in rats. J Cachexia Sarcopenia Muscle (2012) 0.79
Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders. J Neuropathol Exp Neurol (2015) 0.77
Pharmacokinetics and modeling of immune cell trafficking: quantifying differential influences of target tissues versus lymphocytes in SJL and lipopolysaccharide-treated mice. J Neuroinflammation (2012) 0.77